Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Med is a New Delhi-based biotechnology company and a member of the VLCC Healthcare promoter group, specializing in precision medicine through advanced genomic profiling. Founded in 2015, the company provides a comprehensive range of genetic testing services, including pharmacogenomics, clinical genomics, and wellness-focused DNA analysis. Future Med’s technology platform assesses individual genetic risks for chronic conditions like cancer and cardiovascular disease while predicting patient-specific responses to various therapeutic agents. By providing data-driven insights to clinicians and individuals, the company facilitates optimized drug therapy and personalized preventative healthcare in the Indian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Med.